Caas Capital Management LP Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Caas Capital Management LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $1.19 Million - $1.4 Million	-2,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $134,019 - $164,460	-300 Reduced 13.04%	2,000 $946,000
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $956,600 - $1.22 Million	2,000 Added 666.67%	2,300 $1.11 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $1.48 Million - $1.93 Million	-3,000 Reduced 90.91%	300 $187,000
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $1.11 Million - $1.63 Million	3,300 New	3,300 $1.61 Million

1,427

82.1M

835K

1.46M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $111B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.